Similar articles

• Drug safety special: the safety catch.

  Wadman M. Wadman M. Nature. 2005 Mar 31;434(7033):554-6. doi: 10.1038/434554a. Nature. 2005. PMID: 15800591 No abstract available.
• Drug safety special: chasing shadows.

  Frantz S. Frantz S. Nature. 2005 Mar 31;434(7033):557-8. doi: 10.1038/434557a. Nature. 2005. PMID: 15800592 No abstract available.
• Experts call for active surveillance of drug safety.

  Wadman M. Wadman M. Nature. 2007 Mar 22;446(7134):358-9. doi: 10.1038/446358b. Nature. 2007. PMID: 17377551 No abstract available.
• [FDA's new drug approval system].

  Ishii A. Ishii A. Gan To Kagaku Ryoho. 1995 Aug;22(9):1146-51. Gan To Kagaku Ryoho. 1995. PMID: 7661565 Review. Japanese. No abstract available.
• COX-2 inhibitors and the heart: putting risk in perspective.

  Bobadilla RV, Barnett EM, Randels CL. Bobadilla RV, et al. Adv Nurse Pract. 2005 Nov;13(11):48-50. Adv Nurse Pract. 2005. PMID: 16295003 Review. No abstract available.